Patents by Inventor Vijaya Swaminathan

Vijaya Swaminathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20220184002
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: March 8, 2022
    Publication date: June 16, 2022
    Applicant: ALMIRALL, LLC
    Inventors: Kevin S. WARNER, Ajay P. PARASHAR, Vijaya SWAMINATHAN, Varsha BHATT
  • Topical dapsone and dapsone/adapalene compositions and methods for use thereof
    Patent number: 11273132
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: March 15, 2022
    Assignee: ALMIRALL, LLC
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • Topical dapsone and dapsone/adaplene compositions and methods for use thereof
    Patent number: 11116733
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: September 14, 2021
    Assignee: Almirall, LLC
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition
    Patent number: 10213443
    Abstract: The invention relates to a topical suspension formulation that includes a tetracycline, a liquid medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liquid medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 microns.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: February 26, 2019
    Assignee: Hovione Scientia Limited
    Inventors: Mohammad Salman, Arturo Angel, Vijaya Swaminathan, George Magrath
  • TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20180263931
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 20, 2018
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20180243240
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: April 30, 2018
    Publication date: August 30, 2018
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION
    Publication number: 20180177733
    Abstract: Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions.
    Type: Application
    Filed: November 1, 2013
    Publication date: June 28, 2018
    Inventors: Gopi VENKATESH, Vijaya SWAMINATHAN, Jin-Wang LAI
  • RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION
    Publication number: 20180147152
    Abstract: Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions.
    Type: Application
    Filed: January 25, 2018
    Publication date: May 31, 2018
    Inventors: Gopi M. VENKATESH, Vijaya SWAMINATHAN, Jin-Wang LAI
  • TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20170367999
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: September 7, 2017
    Publication date: December 28, 2017
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20170360729
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 21, 2017
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS
    Publication number: 20170266138
    Abstract: Dapsone compositions can be useful for treating acne. The methods and formulations disclosed herein show efficacy for treating acne vulgaris and/or post inflammatory hyperpigmentation.
    Type: Application
    Filed: June 1, 2017
    Publication date: September 21, 2017
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt, Alexandre Kaoukhov
  • TETRACYCLINE TOPICAL FORMULATIONS, PREPARATION AND USES THEREOF IN TREATING AN OCULAR CONDITION
    Publication number: 20170182071
    Abstract: The invention relates to a topical suspension formulation that includes a tetracycline, a liquid medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liquid medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 microns.
    Type: Application
    Filed: March 13, 2017
    Publication date: June 29, 2017
    Applicant: Hovione International Ltd.
    Inventors: Mohammad Salman, Arturo Angel, Vijaya Swaminathan, George Magrath
  • METHODS OF TREATMENT OF ACNE VULGARIS USING TOPICAL DAPSONE COMPOSITIONS
    Publication number: 20170119703
    Abstract: Dapsone compositions can be useful for treating acne. The methods and formulations disclosed herein show efficacy for treating acne vulgaris and/or post inflammatory hyperpigmentation.
    Type: Application
    Filed: November 4, 2016
    Publication date: May 4, 2017
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt, Alexandre Kaoukhov
  • TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20170087102
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • Tetracycline topical formulations, preparation and uses thereof
    Patent number: 9592246
    Abstract: The invention relates to a topical suspension formulation that includes a tetracycline, a liquid medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liquid medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 microns.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: March 14, 2017
    Assignee: Hovione International Ltd.
    Inventors: Mohammad Salman, Arturo Angel, Vijaya Swaminathan
  • Topical dapsone and dapsone/adapalene compositions and methods for use thereof
    Patent number: 9517219
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: December 13, 2016
    Assignee: Allergan, Inc.
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20160243065
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: April 27, 2016
    Publication date: August 25, 2016
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS AND METHODS FOR USE THEREOF
    Publication number: 20160030580
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Application
    Filed: October 16, 2015
    Publication date: February 4, 2016
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • Topical dapsone and dapsone/adaplene compositions and methods for use thereof
    Patent number: 9161926
    Abstract: Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: October 20, 2015
    Assignee: Allergan, Inc.
    Inventors: Kevin S. Warner, Ajay P. Parashar, Vijaya Swaminathan, Varsha Bhatt
  • TETRACYCLINE TOPICAL FORMULATIONS, PREPARATION AND USES THEREOF
    Publication number: 20140147504
    Abstract: The invention relates to a topical suspension formulation that includes a tetracycline, a liquid medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liquid medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 microns.
    Type: Application
    Filed: November 8, 2013
    Publication date: May 29, 2014
    Applicant: HOVIONE INTERNATIONAL LTD.
    Inventors: Mohammad Salman, Arturo Angel, Vijaya Swaminathan